Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 30, 2017

Study Completion Date

January 30, 2017

Conditions
Nonalcoholic SteatohepatitisHypogonadism
Interventions
DRUG

testosterone undecanoate

Preparation: 1 gram in 4 ml of oily base. Requires no special storage conditions. Proposed regime: 1 mg as a single intramuscular injection at 0, 6, 18, 30 and 42 weeks

Trial Locations (1)

S10 2JF

Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT01919294 - Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) | Biotech Hunter | Biotech Hunter